Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease

BACKGROUND: A recent trial involving predominantly Caucasian subjects with Parkinson Disease (PD) showed switching overnight from an oral dopaminergic agonist to the rotigotine patch was well tolerated without loss of efficacy. However, no such data have been generated for Korean patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Han-Joon, Jeon, Beom S, Lee, Won Yong, Lee, Myoung Chong, Kim, Jae Woo, Kim, Jong-Min, Ahn, Tae-Beom, Cho, Jinwhan, Chung, Sun Ju, Grieger, Frank, Whitesides, John, Boroojerdi, Babak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166898/
https://www.ncbi.nlm.nih.gov/pubmed/21831297
http://dx.doi.org/10.1186/1471-2377-11-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166898/
https://www.ncbi.nlm.nih.gov/pubmed/21831297
http://dx.doi.org/10.1186/1471-2377-11-100

Ejemplares similares